Introduction
The recognized causes of death from solvent abuse include anoxia, vagal inhibition, respiratory depression, cardiac arrhythmias, trauma and suicide. ' The number of deaths attributable to the inhalation of fuel gases and pressurized aerosols is increasing in the United Kingdom and over the last few years has nearly doubled in males aged 10-19 years. 2 We report a case of solvent abuse resulting in fatal fulminant hepatic failure.
Case report
A 17 year old male Caucasian was admitted to a surgical ward with a 10 h history of abdominal pain and vomiting. He was flushed but apyrexial and had a fetor with a mildly tender abdomen especially on the right. Full blood count was normal. The pain settled after 24 h observation. A barium meal to investigate the vomiting revealed situs inversus partialis, but was otherwise normal.
During the next day he became progressively more agitated and showed bizarre behaviour. He developed hepatomegaly, polyuria and jaundice. Inquiries revealed that the patient had been abusing butane aerosols (5 to 10 cans per day) for 3 years. The patient admitted taking a proprietary engine or carburettor cleaner (Table I) Several of the compounds in the engine or carburettor cleaner might have been involved in the toxic reaction including alcohols and toluene derivatives. Isopropyl alcohol appears to be more toxic than ethanol and toxicity has been reported with ingestion of as little as 20 ml.7 It undergoes hepatic metabolism to acetone. As with many industrial compounds8 there is little information (Medline & Toxline literature searches) on the excretion and toxicology of the other compounds in the cleaners, though oleic acid is unlikely to be the cause. Encephalopathy but not hepatotoxicity has been reported with petrol inhalation.9"10 Enzyme induction is known to predispose to the toxic effect of carbon tetrachloride on the liver,3 and alcohol probably enhances renal damage due to chlorinated hydrocarbons.4 Our patient may have had microsomal enzyme induction as a result of longstanding and heavy abuse ofbutane and this may have resulted in the rapid and severe nature of the liver damage. A total of 30-45% of an inhaled dose of butane is absorbed and though most is excreted unchanged via the lungs a small amount is probably metabolized in the liver."
The predominance of abdominal pain in this patient's symptomology resulted in admission to a surgical ward for observation. Abdominal pain may be a feature of hepatitis2 and was a marked feature of 'Eppingjaundice', a hepatotoxic reaction to an aromatic amine dissolved in butyrolactone.'2 Clinicians should remain alert to the possibility of toxin or drug ingestion as a cause for non-specific symptoms including pain and vomiting. This case demonstrates that hepatic dysfunction with solvent abuse can be severe or life threatening and may present in rather unusual ways. Clinical suspicion and early investigation (e.g. prothrombin time) should permit early recognition and the prompt instigation of supportive measures. 
